"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

Mankind Pharma Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln	Chairman : RAMESH CHAND JUNEJA
Home : Indian Private	Book Value: 375.7767853
BSE Code : 543904	Market Cap: 93419.63
NSE Code : MANKIND	P / E : 56.06

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Type	2Qtr	1Qtr	4Qtr	3Qtr
Net Sales	2608.78	2541.36	2126.59	2414.41
Other Income	77.67	64.22	219.32	70.37
Total Income	2686.45	2605.58	2345.91	2484.78
Total Expenditure	1915.59	1868.29	1649.67	1668.31
Operating Profit	770.86	737.29	696.24	816.47
Interest	147.20	146.70	162.25	200.27
Gross Profit	623.66	590.59	533.99	616.20
Depreciation	99.03	96.93	105.24	91.11
Tax	97.54	92.14	93.07	135.85
Deferred Tax	-31.81	-11.24	-46.78	-22.78
Reported Profit After Tax	458.90	412.76	382.46	412.02

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527

Content powered by Capital Market Charts are powered by TradingView